References
- Isolation and Identification of Drugs in Pharmaceuticals, Body Fluids, and Post Mortem Material, E. G. C. Clarke. The Pharmaceutical Press, London 1969
- Cochin J., Daly J. W. J. Pharmacol. Exptl. Therap. 1963; 139: 160–165
- De Silva J. A. F., Koechlin B. A., Bader G. J. Pharm. Sci. 1966; 55: 692–702
- Eschenhof E., Reider J. Arzneim‐Forsch. 1969; 19: 957–966
- Forbes G., Weir W. P., Smith H., Bogan J. J. Forensic Sci. 1965; 5: 183–187
- Goodman L. S., Gilman A. The Pharmacological Basis of Therapeutics3rd ed. The MacMillan Company, New York 1965
- Huang C. L. Intern. J. Neuropharmacol. 1967; 6: 1–13
- Koechlin B. A., Schwartz M. A., Krol G., Oberhausli W. J. Pharmacol. Exptl. Therap. 1965; 148: 399–411
- Kofoed J., Korczak‐Fabierkiewicz C., Lucas G. H. Nature 1966; 211: 410–416
- Munksgaard E. C. Acta Pharmacol. Toxicol. 1969; 27: 129–134
- Randall L. O. Diseases Nervous System. 1961; 22: 7–15
- Roche Laboratories Product Reference Manual. Roche Laboratories, Nutley, New Jersey
- Ruelius H. W., Lee J. M., Auburn H. E. Arch. Biochem. Biophys. 1965; 111: 376–380
- Schwartz M. A., Koechlin B. A., Postma E., Palmer S., Krol G. J. Pharmacol. Exptl. Therap. 1965; 149: 423–435
- Schwartz M. A., Vane F. M., Postma E. Biochem. Pharmacol. 1966; 17: 965–974
- Tompsett S. L. Acta Pharmacol. Toxicol. 1968; 26: 303–315
- Van der Kleign E. Arch. Intern. Pharmacodyn. Therap. 1969; 178: 193–215
- Viala A., Cano J. P., Philippe F. Ann. Pharm. Franc. 1969; 27: 511–518
- Wallace J. E., Biggs J. D., Ladd S. L. Anal. Chem. 1968; 40: 2207–2210